期刊文献+

2型糖尿病患者注射利拉鲁肽后出现房室传导阻滞一例报道 被引量:2

Atrioventricular block after Liraglutide injection:A case report
原文传递
导出
摘要 本文报道1例T2DM患者注射利拉鲁肽后心电图显示房室传导阻滞。提示临床医生在使用利拉鲁肽的同时,应密切关注其心电图变化,尤其当患者合并心脏疾病或使用一些可能影响房室传导的药物时。 Onset of atrioventricular block in a T2DM patient after Liraglutide injection showed by electrocardiogram(ECG)is reported in this article,which is supposed to remind clinicians to pay close attention to the changes of ECG when using Liraglutide,especially for those with heart disease or using drugs that may affect atrioventricular conduction function.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第12期1121-1123,共3页 Chinese Journal of Diabetes
关键词 糖尿病 2型 利拉鲁肽 房室传导阻滞 Diabetes mellitus type 2 Liraglutide Atrioventricular block
  • 相关文献

参考文献10

  • 1Nan& M, Frid A, Hermansen tC et al. Efficacy and safety compar- ison of liraglutide,glimepiride, and placebo, all in combination with metfonnin,in type 2 diabetes: the LEAD (liraglutide effect and ac- tion in diabetes)-2 study. Diabetes Care,2009,32:84-90.
  • 2Buse JB, Rosenstock J, Sesti G, et al. Liraglutide once a day ver- sus exenatide twice a day for type 2 diabetes: a 26-week ran- domised,parallel-group,multinational,open-label trial (LEAD- 6). Lancet, 2009,374: 39-47.
  • 3Marre M, Shaw J, Brandle M, et al. Liraglutide, a once-daily hu- man GLP-1 analog, added to a sulfonylurea offers significantly better glycemie control and favorable weight change compared with rosiglitazone and SU combination therapy in subjects with type 2 diabetes. Diabetes, 2008,57 (Suppl 1) : 4.
  • 4Garber A, Henry R, Ratner R, et al. Liraglutide versus glimepiride monotherapy for type 2 diabetes: a randomised, 52-week, phase Ill, double blind,parallel-treatment trial. Lancet,2009,373:473-481.
  • 5Knezevich E, Crnic T, Kershaw S, et al. Liraglutide-associate- dacutepancreatitis. Am J Health Syst Pharm, 2012, 69: 386-389.
  • 6Kaakeh Y,Kanjee S,Boone K, et al. Liraglutide-induced acute kidney injury. Pharmacotherapy, 2012,32 : e7-el 1.
  • 7Besemer F, Verschoor AJ, Diamant M, et al. Vesiculopustular dermatosis., an uncommon side-effect of liraglutide?. J Diabetes Complications, 2012,26 : 458-459.
  • 8Griffioen KJ,Wan R,Okun E et al. GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons. Cardiovasc Res, 2011,89 : '/2-78.
  • 9Yamamoto H, Lee CE, Marcus JN et al. Glucagonqike peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest, 2002, 110:43-52.
  • 10Bharucha AE, Charkoudian N, Andrews CN et al. Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation onsympathetic and parasympathetic activity in humans. Am J Physiol Regul Integr Comp Physiol, 2008,295 : R874-R880.

同被引文献32

引证文献2

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部